Trials / Completed
CompletedNCT01995786
Clinical Outcomes and Costs Analyses in Use of Goal Directed Therapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Regina Elena Cancer Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to evaluate clinical and economic impact of Goal Directed Fluid Therapy according to NICE haemodynamic protocol. Haemodynamic parameters were assessed using automated pulse contour analysis (Flotrac/Vigileo®). A specific dedicated software has been developed to perform clinical and expenditures data collection, both retrospective and prospective data are archived.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Goal Directed Fluid Therapy FloTrac/Vigileo |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2014-12-01
- First posted
- 2013-11-27
- Last updated
- 2016-04-07
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01995786. Inclusion in this directory is not an endorsement.